[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338143-105":59,"doc-detail-338143-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","activin-levels-correlate-with-lymphocytic-infiltration-in-epithelial-ovarian-cancer","Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer","","Objective focuses on activin, a TGF-β superfamily member, and its unclear immune role in epithelial ovarian cancer (EOC). The study compares activin components (INHBA/INHBB) across malignant versus ovarian tissues at RNA and protein levels, and evaluates links between activin and immune cells. Methods integrate GEO RNA-seq with DESeq2, TCGA-OV immune profiling, immunohistochemistry for activin A with CD8 and FOXP3, and ELISA measurements of activin-A in patient ascites. Results and conclusion report pathway activation, immune-marker correlations, and worse survival associations.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/activin-levels-correlate-with-lymphocytic-infiltration-in-epithelial-ovarian-cancer/338143/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/activin-levels-correlate-with-lymphocytic-infiltration-in-epithelial-ovarian-cancer/338143.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study on activin in epithelial ovarian cancer?","Question",{"text":113,"@type":114},"To determine differences in activin (INHBA/INHBB) between malignant and ovarian tissues and assess how activin relates to immune cells in EOC.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which datasets and laboratory approaches are used to measure activin and immune associations?",{"text":118,"@type":114},"Public GEO RNA-seq data are analyzed with DESeq2, immune expression is explored in the TCGA-OV cohort, immunohistochemistry evaluates activin A with CD8 and FOXP3, and ELISA quantifies activin-A in ascites from advanced EOC patients.",{"name":120,"@type":111,"acceptedAnswer":121},"What key findings link activin to immune cell infiltration and patient outcomes?",{"text":122,"@type":114},"Activin signaling pathway components are elevated in EOC, INHBA expression correlates with lymphocytic immune markers, and protein-level immunohistochemistry shows a positive correlation between CD8/FOXP3 staining and activin A; activin is associated with worse survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338143,1790295648,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","DOI: 10. 1002/cam4 .7368  \nRESEAR CH ARTICLE  \nActivin levels correlate with lymphocytic infiltration in epithelial ovarian cancer  \nElizabeth T. Evans1  | Emily F. Page2 | Alex Seok Choi2 | Zainab Shonibare2 | Andrea G. Kahn2 | Rebecca C. Arend1 | Karthikeyan Mythreye2   \n1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Heersink School of Medicine, University of Alabama School of Medicine, Birmingham, Alabama, USA  \n2Department of Pathology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA  \nCorrespondence  \nKarthikeyan Mythreye, Division of Molecular and Cellular Pathology, Department of Pathology, Molecular Cellular, O'Neal Comprehensive Cancer Center, University of Alabama Heersink School of Medicine, Birmingham, AL, USA. [Email:](Email: mythreye@uab.edu)[ mythreye@uab.edu](Email: mythreye@uab.edu)  \nRebecca C. Arend, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama Heersink School of Medicine, Birmingham, AL, USA. Email: [rarend@uabmc.edu](rarend@uabmc.edu)  \nFunding information  \nDivision of Cancer Prevention, National Cancer Institute, Grant/Award Number: NCI R01CA219495 and NCIT32CA229102  \nAbstract  \nObjective: The TGF-β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin-βA and INHBB/ Inhibin-βB) between malignant and ovarian tissues atthe RNA and protein level and assess the relationship between activin and immune cells in EOC.  \nMethods: Publicly available RNA sequencing data were accessed from GEO (\\#GSE143897) with normalization and quantification performed via DESeq2 . Immune gene expression profile was further explored within the TCGA-OV cohort derived from The Cancer Genome Atlas (TCGA) . Immunohistochemical analysis was performed to evaluate activin A and T-cell markers CD8 and FoxP3 at the protein level. ELISA to activin-A was used to assess levels in the ascites of advanced EOC patients. Kaplan–Meier curves were generated to visualize survival outcomes.  \nResults: Gene expression levels of components of the activin signaling pathway were elevated within EOC when compared to a benign cohort, with differences in activin type I/II receptor gene profiles identified. Additionally, INHBA gene expression was linked to lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of CD8 and FOXP3 staining with activin A at the protein level in both primary and metastatic epithelial ovarian cancer samples. Furthermore, Activin-A (inhibin-βA) is significantly elevated in EOC patient ascites.  \nConclusion: INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration. Our findings suggest that activin-A may play a role in suppressing anti-tumor immunity in EOC, highlighting its potential as a therapeutic target.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e7368 .  \n[https://doi.org/10.1002/cam4.7368](https://doi.org/10.1002/cam4.7368)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 11  \nKEYWORDS  \nactivin, metastasis, ovarian cancer, tumor immune infiltration  \n1 | INTRODUCTION  \nOvarian cancer remains the eighth most common cause of cancer-related deaths worldwide and has the highest mortality rate of the gynecologic malignancies. Within the United States, an estimated 19,880 women were diagnosed with ovarian cancer in 2022, with 12,810 women succum","cbCaibwy3mLIiBUk","https://ap.wps.com/l/cbCaibwy3mLIiBUk","pdf",5925522,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main objective of the study on activin in epithelial ovarian cancer?\",\"answer\":\"To determine differences in activin (INHBA/INHBB) between malignant and ovarian tissues and assess how activin relates to immune cells in EOC.\"},{\"question\":\"Which datasets and laboratory approaches are used to measure activin and immune associations?\",\"answer\":\"Public GEO RNA-seq data are analyzed with DESeq2, immune expression is explored in the TCGA-OV cohort, immunohistochemistry evaluates activin A with CD8 and FOXP3, and ELISA quantifies activin-A in ascites from advanced EOC patients.\"},{\"question\":\"What key findings link activin to immune cell infiltration and patient outcomes?\",\"answer\":\"Activin signaling pathway components are elevated in EOC, INHBA expression correlates with lymphocytic immune markers, and protein-level immunohistochemistry shows a positive correlation between CD8/FOXP3 staining and activin A; activin is associated with worse survival.\"}]","Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer | PDF",1790022177,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1a154eb22c346508732858c6d3bbb04.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/159cd4497f9e430dfc46bdd3ac2dadca.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfc86951ed353ad071c35a5dbf1313bc.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9de091913e2d0cc4d8b3a97b3c870002.webp",980,1287]